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Mosquito-transmitted malaria parasites infect hepa-
tocytes and asymptomatically replicate as liver
stages. Using RNA sequencing, we show that a
rodent malaria liver-stage infection stimulates a
robust innate immune response including type I
interferon (IFN) and IFNg pathways. Liver-stage
infection is suppressed by these infection-engen-
dered innate responses. This suppression was abro-
gated in mice deficient in IFNg, the type I IFN a/b
receptor (IFNAR), and interferon regulatory factor 3.
Natural killer and CD49b+CD3+ natural killer T (NKT)
cells increased in the liver after a primary infection,
and CD1d-restricted NKT cells, which secrete IFNg,
were critical in reducing liver-stage burden of a sec-
ondary infection. Lack of IFNAR signaling abrogated
the increase in NKT cell numbers in the liver, showing
a link between type I IFN signaling, cell recruitment,
and subsequent parasite elimination. Our findings
demonstrate innate immune sensing of malaria para-
site liver-stage infection and that the ensuing innate
responses can eliminate the parasite.
INTRODUCTION
Plasmodium parasites, the causative agents of malaria, infect
approximately 300–500 million people each year, which results
in the deaths of 267,000 people annually (World Health Organiza-
tion, 2013). Mammalian infection is initiated following the bite of a
mosquito carrying infectious sporozoites, which are inoculated
into the dermis. These sporozoites actively enter the blood-
stream and are transported to the liver, where they invade a he-
patocyte within which they grow and develop as liver stages.
Each parasite undergoes replication, leading to an enormous in-
crease in parasite biomass and culminating in the release of
10,000–50,000 infectious exoerythrocytic merozoites into the
blood (reviewed in Lindner et al., 2012). Thesemerozoites initiate
cyclical asexual intraerythrocytic replication responsible for the
pathological manifestations of blood-stage malaria infection.
Innate immune responses are the first line of defense against
invading pathogens and are integral in shaping the adaptive
immune response necessary for long-term antigen-specific pro-436 Cell Reports 7, 436–447, April 24, 2014 ª2014 The Authorstection against pathogens. Blood-stage Plasmodium parasite
infection generates robust innate immune responses that have
been extensively studied and are predominantly mediated by
interferon g (IFNg), tumor necrosis factor a, and interleukin-12
(reviewed in Riley and Stewart, 2013). However, innate immune
responses generated during pre-erythrocytic (sporozoite and
liver stages) infection remain undefined. Understanding if and
how the host detects and responds to liver-stage parasites is
important, because relatively few parasites establish a produc-
tive infection in hepatocytes under natural transmission condi-
tions. Thus, an effective innate immune response against a small
number of parasites during this point in the infection cycle could
inhibit the onset of disease.
A small number of previous studies in rodentmodels ofmalaria
have examined the induction of innate immune responses by
pre-erythrocytic Plasmodium parasites (reviewed in Liehl and
Mota, 2012). Histopathology on livers infected with either
P. yoelii (Py) or P. berghei sporozoites revealed the presence
of cellular infiltrates that form foci late during liver-stage develop-
ment around the time of exoerythrocytic merozoite release (Khan
and Vanderberg, 1991; Mack et al., 1978). These studies initially
identified these cellular infiltrates as being predominantly eosin-
ophils and neutrophils (Khan and Vanderberg, 1991, 1992).
Other studies have shown that natural killer (NK) cells (Pied
et al., 2000; Roland et al., 2006) and natural killer T (NKT) cells
(Soulard et al., 2007) infiltrate the liver following infection, but
this is after the liver-stage infection has progressed to a blood-
stage infection. It is difficult to study the effect of innate immune
responses on primary pre-erythrocytic infection, because the
peak of the innate immune response occurs at the end of liver-
stage development, just prior to or concurrent with exoerythro-
cytic merozoite release. Thus, the antiparasitic effects of innate
immune responses engendered by pre-erythrocytic parasites
remain unknown.
Here, we analyze the innate immune response induced by Py
parasites in the liver using wild-type (WT) parasites and attenu-
ated parasites that are incapable of progressing to blood-stage
infection. Analysis of RNA sequencing (RNA-seq) gene expres-
sion data from the livers of infectedmice revealed that pre-eryth-
rocytic stage parasites induce an innate immune response that is
mediated by type I IFNs and IFNg resulting in the reduction of
parasites in the liver. Primary liver infections with attenuated par-
asites suppress a secondary liver-stage parasite infection with
WT parasites, providing a robust method to measure the func-
tional consequences of the liver-stage innate immune responses
in vivo. Suppression of infection was abrogated in mice deficient
in type I IFN signaling pathways and in the effector cytokine IFNg.
We further show that this innate immune response is dependent
upon NKT cells, which secrete IFNg and increase in the liver
following parasite infection in WT mice, but not type I inter-
feron-a/b receptor (IFNAR)-deficient mice.
RESULTS
Comparative RNA-Seq Reveals an Induction of
IFN-Mediated Signaling Pathways following
Plasmodium Liver-Stage Infection
Gene expression analysis has been effectively utilized in multiple
models to identify innate immune responses to infection (Diercks
and Aderem, 2013; Liehl et al., 2014). The few previous studies
conducting histological analysis of innate immune cell responses
to Plasmodium pre-erythrocytic infection have reported that
immune cells infiltrate the liver between 48 and 72 hr postinfec-
tion (hpi) with rodent malaria sporozoites (Khan and Vanderberg,
1991, 1992; Liehl et al., 2014). Thus, we initially examined
changes in gene expression during liver-stage infection in mice
at 72 hpi. Infection with WT Py sporozoites progresses to the
blood stage after about 50 hpi. In order to ensure that measured
responses at 72 hpi are only caused by liver infection and not by
the ensuing blood-stage infection, we utilized an attenuated
P. yoelii parasite (PyA) that develops to late liver-stage forms
but does not progress to blood-stage infection (Vaughan et al.,
2009). Gene expression data derived from both C57BL/6 and
BALB/cJ mouse livers (n = 4) 72 hpi following mock infection
with salivary gland material from uninfected mosquitoes (mock)
or attenuated PyA sporozoite infection was analyzed using
RNA-seq (Tables S1 and S2). Transcript levels that changed
by at least a factor of four (log2 fold change of ±2) with a
p value < 0.01 were considered significant. A total of 75 tran-
scripts were significantly up- or downregulated in C57BL/6
mice following PyA infection (69[, 6Y) (Figures 1A and 1B).
Comparatively, 200 transcripts in BALB/cJ mice were differen-
tially regulated (198[, 2Y) (Figures 1A and 1C). A total of 42 tran-
scripts were upregulated in bothmouse strains (Figure 1A), many
of which encode factors involved in innate immune responses
(Figure 1D). Pathway analysis of differentially expressed genes
was carried out using the Ingenuity IPA software package and
the Upstream Regulator Analysis tool to identify the molecular
regulators that explain the observed gene expression signatures.
Interestingly, IFNg and IFNb were significant regulators of the
observed innate immune response to infection in both mouse
strains (Figures 1E and 1F). Furthermore, STAT1, a transcription
factor shared by both type I and type II IFN signaling pathways
(Stark and Darnell, 2012), was also a major regulator of the
observed transcriptional changes (Figures 1E and 1F). Gene
expression was additionally carried out at an earlier time point,
24 hpi, and also revealed that IFN-mediated pathways were up-
regulated, although fewer genes were differentially regulated at
this time point (BALB/cJ: 125; C57BL/6: 51) (Figure S1; Tables
S3 and S4). To confirm the gene expression data, we monitored
IFNb and IFNg protein levels in mice 72 hpi by ELISA. IFNb was
not measurable in the livers of mock-infected mice but was de-
tected in the livers of PyA-infected mice (Figure 1G). Similarly,IFNg was detectible in the sera of PyA-infected mice, but not
in mock-infected mice (Figure 1H). Importantly, the liver-stage
burden following infection with 50,000 WT Py sporozoites in
IFNg/ mice was approximately twice that of infected WT
C57BL/6 mice as determined by quantitative PCR (qPCR) (Fig-
ure S2). This suggests that the innate upregulation of IFNg
following pre-erythrocytic infection leads to a reduction in liver-
stage burden.
Primary Plasmodium Liver-Stage Infection Inhibits a
Secondary Liver-Stage Infection
Having established that Plasmodium pre-erythrocytic stage par-
asites induce an IFN-driven innate immune response in the liver,
we next sought to generate a robust model that would enable us
to measure the induction of this innate immune response and
determine the functional significance of the response on liver-
stage parasites. To this end, we infected mice after the primary
infection for a second time with WT Py sporozoites in order to
determine if the impact of the innate response on this secondary
infection could be used as a functional measure (Figure 2A).
Because PyA does not complete liver-stage development and
does not transition to the blood-stage infection (Vaughan et al.,
2009), its use in the primary infection allowed us to evaluate
the effect of a liver-stage-engendered innate immune response
on a secondary infection at time points greater than 48 hr after
the primary infection. Conversely, primary infection with WT Py
sporozoites leads to blood-stage infection after approximately
50 hr. This blood-stage infection engenders its own innate im-
mune response, which would mask the liver-stage-specific
innate immune response. BALB/cJ mice were mock infected
or infected with 100,000 WT Py or PyA sporozoites on day 1
(primary infection). On day 0, the mice were infected with
50,000 Py sporozoites (secondary infection) that constitutively
express a GFP-luciferase fusion protein (PyGFP-luc) (Miller
et al., 2013). Liver-stage burden of PyGFP-luc-infected mice
was monitored at 24 and 43 hpi by bioluminescent imaging (Fig-
ure 2A). Mock-infected mice supported a robust PyGFP-luc
secondary infection at 24 and 43 hpi, whereas the secondary
infection in both Py- and PyA-infected mice was reduced by
approximately 70-fold at both time points (Figures 2B and 2C).
The reduction of PyGFP-luc liver-stage burden observed at
24 hpi in mice given either a Py or PyA primary infection can
be attributed to the effects of the innate immune response
generated by the primary pre-erythrocytic infection. This reduc-
tion of PyGFP-luc secondary infection was further confirmed
by qPCR analysis of infected livers at 43 hpi (Figure 2D) and
by examining the time to blood-stage patency. Reduced time
to patency is indicative of a reduction of liver-stage burden
that leads to a lower number of exoerythrocytic merozoites
produced and thus delayed occurrence of detectable blood-
stage infection. In these types of studies, a 1-day delay in time
to patency correlates to an approximate 90% reduction in
liver-stage burden (Gantt et al., 1998). To this end, mock- or
PyA-infected BALB/cJ mice were administered a secondary
infection with either 50,000 or 1,000 PyGFP-luc sporozoites,
and subsequent blood-stage infection was monitored by
microscopic evaluation of Giemsa-stained blood smears
(Table 1). After infectious sporozoite challenge of mice thatCell Reports 7, 436–447, April 24, 2014 ª2014 The Authors 437
Figure 1. Comparative Gene Expression
Analysis Reveals an Induction of IFN-Medi-
ated Signaling Pathways by Plasmodium
Liver-Stage Infection
Gene expression analysis of RNA from the livers of
mock- (material from uninfected mosquito salivary
glands) or PyA-infected BALB/cJ or C57BL/6mice
(72 hpi) was subjected to a comparative RNA-seq
experiment to identify significant differences in
transcript abundances following PyA infection
(jlog2fold changejR 2; p < 0.01).
(A) Venn diagram depicting the total number of
significantly changed transcripts in BALB/cJ mice
(red; 242) and C57BL/6 mice (blue; 75) following
PyA infection. Transcripts common to both data
sets are represented by the overlay.
(B and C) Scatterplots comparing normalized
transcript abundance between mock- and PyA-
infected C57BL/6 (B) and BALB/cJ (C) mice.
Upregulated (BALB/cJ = 198; C57BL/6 = 69) and
downregulated (BALB/cJ = 2; C57BL/6 = 6) tran-
scripts are located at positions significantly away
from the diagonal line on a scatterplot.
(D) Subset of innate immunity-related transcripts
that were significantly upregulated following PyA
infection in both BALB/cJ and C57BL/6 mice.
(E and F) Upstream regulator analysis. Data sets
from (A) were analyzed using Ingenuity IPA up-
stream regulator analysis tool. The top five up-
stream regulators that direct immune responses in
BALB/cJ (E) and C57BL/6 (F) mice after Plasmo-
dium infection are listed along with the corre-
sponding Z scores and p values. Z scores infer
the activation states of predicted transcriptional
regulator. A positive Z score designates activation
by a transcriptional regulator, whereas a negative
Z score designates inhibition. Z scores greater
than 2 or smaller than 2 are considered signifi-
cant. Overlap p value measures whether there is a
statistically significant overlap between the data
set genes and the genes that are regulated by a
transcriptional regulator (Fisher’s exact test).
(G and H) Cytokine ELISAs. (G) IFNb was detected
in liver homogenates from mock- and PyA-in-
fected BALB/cJ and C57BL/6 mice by ELISA at
72 hpi. (H) IFNg in the serum of mock- and PyA-
infected BALB/cJ or C57BL/6 mice 72 hpi was
measured by ELISA. Bar graphs represent mean ±
SD of the data.
See also Tables S1, S2, S3, and S4 and Figures S1
and S2.had received a prior primary infection with PyA, onset of
blood-stage infection was delayed 2.5 days (for a 50,000
sporozoite challenge) or 1.5 days (for a 1,000 sporozoite
challenge) compared to the mock primary controls challenged
with the same sporozoite doses (Table 1). Furthermore, only
40% of PyA primary-infected mice became blood-stage patent
following a secondary infection with 1,000 PyGFP-luc sporozo-
ites, again confirming the ability of a primary liver-stage infec-
tion to initiate an innate immune response that eliminates
subsequent infection (Table 1). These data show that WT (Py)
and attenuated (PyA) parasites induce a comparable innate
immune response that impacts liver-stage infection. Thus, we
were confident that we could use the PyA parasite in further438 Cell Reports 7, 436–447, April 24, 2014 ª2014 The Authorsstudies to model the impact of an innate immune response on
liver-stage infection.
Because most knockout mice are available only on the
C57BL/6 background, we also adapted our infection assay to
this strain. Our previous RNA-seq analysis revealed that
C57BL/6 mice induced a strong transcriptional response to
infection at 72 hpi. Correspondingly, the time interval between
the primary and secondary infection used in the BALB/cJ
assaywas increased from 24 hpi to 72 hpi for theC57BL/6 assay.
Liver-stage burden of the secondary PyGFP-luc infection was
monitored by bioluminescent imaging at 24 and 44 hpi. As
seen in BALB/cJ mice, mock-infected C57BL/6 mice supported
a robust PyGFP-luc secondary infection at 24 and 44 hpi,
whereas the secondary infection in PyA primary-infected mice
was reduced by greater than 100-fold at both time points (Fig-
ure 2E). This reduction in liver burden was further confirmed
by qPCR analysis (Figure 2F) and blood-stage patencymeasure-
ments (Table 1).
To confirm that the model would also show the induction of an
innate immune response via mosquito bite infection, we per-
formed a secondary PyGFP-luc infection on mice previously
exposed to the bites of 15 PyA-infected mosquitoes. Indeed,
the secondary PyGFP-luc infection was significantly reduced in
mice preinfected with PyA as compared to mock-infected mice
(Figure 2G), showing that a natural route of infection also induces
an innate immune response capable of reducing liver-stage
parasite infection.
Functionality of the Innate Immune Response Is
Dependent on Both Type I and II IFNs
Our gene expression data revealed that type I IFNs regulated
many of the innate pathways upregulated in liver-stage-infected
mice (Figure 1E, F). To assess the functional role of type I IFN
signaling in eliminating liver-stage parasites, we used our model
to study infections in IFNAR/ mice, which are unable to
respond to type I IFNs due to the lack of the partner receptor.
As we observed previously (Figure 2E), in C57BL/6 mice given
a primary PyA infection, liver-stage burden of a PyGFP-luc sec-
ondary infection was reduced greater than 100-fold when
compared to mock-infected mice. However, in IFNAR/ mice,
the PyGFP-luc secondary infection was reduced by only 2-fold
when comparing PyA to mock primary infection (Figures 3A
and 3B), indicating that type I IFN signaling is critical for innate
immune elimination of liver stages.
The induction of a type I IFN response is dependent upon the
transcription factors interferon regulatory factor (IRF) 3 and IRF7,
which can function as either homo- or heterodimers. While IRF3
is activated by phosphorylation, IRF7 is transcriptionally regu-
lated and is induced following activation of a type I IFN response
(Cavlar et al., 2012). Indeed, IRF7 mRNA was upregulated in the
livers of PyA-infected mice at both 24 and 72 hpi (Tables S2 and
S4). Interestingly, in our model infection assay, PyA infected
IRF3/ mice only reduced their secondary liver-stage infection
with PyGFP-luc by 10-fold compared to a mock primary infec-
tion, in stark contrast to the 100-fold decrease in liver-stage
burden seen in control C57BL/6 mice (Figure 3C). However,
IRF7/ mice reduced the secondary infection similar to control
C57BL/6 mice (Figure 3D). This suggests that IRF3, but not IRF7,
is important for the induction of the type I IFN-induced innate
immune response produced by a liver-stage infection. IRF3
can be activated through downstream signaling by pathogen
associated molecular patterns (PAMPs) that bind to Toll-like
receptor (TLR) 3 or 4 and signal through the signaling adaptor
TIR-domain-containing adaptor-inducing interferon-b (TRIF) or
through cytoplasmic nucleic acid receptors such as melanoma
differentiation-associated protein 5 (MDA5) and stimulator of
interferon genes (STING) that signal through mitochondrial anti-
viral signaling protein (MAVS) (Cavlar et al., 2012). However,
these signaling molecules (TLR3, TLR4, TRIF, MDA5, STING,
andMAVS) did not appear to be critical in the induction of a func-
tional innate immune response against liver stages, given thatmice deficient in these molecules were not impaired in their abil-
ity to reduce a secondary liver-stage infection when compared to
WT controls (Figure S3).
Our gene expression analysis also revealed IFNg to be a signif-
icant regulator of the liver-stage-induced innate immune response
(Figures 1E and 1F). To determine the functionality of the IFNg
response in reducing liver-stage parasite infection, we utilized
IFNg-deficient mice in our model infection assay. As before, PyA
primary-infected C57BL/6mice were able to substantially reduce
the liver-stage burden of a secondary PyGFP-luc infection as
compared to mock-infected mice, whereas IFNg-deficient mice
were not (Figure 3E). These data implicate IFNg as a keymediator
of innate immune control of liver-stage parasites.
Lymphocyte Populations Increase in the Liver Shortly
after Plasmodium Liver-Stage Infection
Type I IFNs can be produced by many cell types in response to
microbial stimuli, whereas IFNg can only be secreted by acti-
vated lymphocytes, typically activated T cells, NKT cells, and
NK cells (Schoenborn and Wilson, 2007). To determine the dy-
namics of these lymphocyte populations following sporozoite
infection, we monitored the populations of lymphocytes in the
livers of mock- or PyA-infected C57BL/6 mice by flow cytometry
72 hpi. Identification of NK and NKT cells was based on expres-
sion of CD49b and CD3, whereas CD8+ and CD4+ T cells were
classified based on surface expression of CD3, CD8, and CD4
(Figure 4A). An approximate 2-fold increase in the percentage
of NK cells (CD49b+CD3) (Figure 4B) and CD49b+CD3+ NKT
cells (Figure 4C) was observed in the livers of PyA-infected
C57BL/6 mice as compared to mock-infected mice. Approxi-
mately 50% of CD49b+CD3+ cells also bound CD1d tetramer,
suggesting that this population includes CD1d-restricted NKT
cells (Figure S4). However, the overall percentage of CD1d
tetramer-positive cells decreased following PyA infection (Fig-
ure S4) in a manner similar to that observed following infections
with other hepatotropic pathogens (Gao et al., 2009). The per-
centage of CD8+ T cells (CD3+CD8+) also increased in the livers
of infectedmice by about 30% (Figure 4D), whereas the percent-
age of CD4+ T cells (CD3+CD4+) slightly decreased (Figure 4E).
Thus, PyA infection alters the lymphocyte composition of the
liver, providing clues as to which cell types may be mediating
the IFNg-dependent innate immune reduction of liver-stage
burden.
CD1d-Restricted NKT Cells Are Necessary to Inhibit
Liver-Stage Infection
IFNgmediates the killing of liver-stage parasites in vitro (Mellouk
et al., 1991; Schofield et al., 1987) and could be responsible for
the parasite-induced innate immune inhibition of infection we
have observed. Thus, we first sought to determine if lympho-
cytes were necessary for the innate reduction of liver-stage
burden by performing infections in FRG triple-knockout mice
(FAH/; RAG2/; IL2Rg/), which are deficient in B, T, NK,
and NKT cells (Azuma et al., 2007). PyA-infected FRG knockout
mice were unable to reduce a PyGFP-luc secondary infection
when compared to mock-infected mice, suggesting that lym-
phocytes are indeed necessary for innate elimination of a sec-
ondary liver-stage infection (Figure 5A).Cell Reports 7, 436–447, April 24, 2014 ª2014 The Authors 439
(legend on next page)
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Table 1. Primary Infection Results in a Decrease in Time to
Patency of a Superinfection
Strain Condition
Number of Mice
(Patent/Total)
Average Day
to Patency
BALB/cJ 50K PyGFP-luc 5/5 3
PyA/ 50K PyGFP-luc 5/5 3
1K PyGFP-luc 5/5 3
PyA/ 1K PyGFP-luc 2/5 5.5
C57BL/6 50K PyGFP-luc 5/5 3
PyA/ 50K PyGFP-luc 5/5 4.5
1K PyGFP-luc 5/5 3
PyA/ 1K PyGFP-luc 1/5 6
BALB/cJ and C57BL/6 mice were mock infected or infected intrave-
nously with 100,000 PyA sporozoites. Mice received a secondary infec-
tion at 24 (BALB/cJ) or 72 (C57BL/6) hpi with either 50,000 or 1,000
PyGFP-luc sporozoites. Blood-stage patency was monitored in mice
by the Giemsa staining of daily blood smears.We next attempted to identify which lymphocyte populations
significantly contribute to innate reduction of liver-stage infec-
tion. Depletion of CD4+ or CD8+ T cells using CD4- or CD8-
specific antibodies had no effect on the ability of PyA liver-
stage-infected C57BL/6 mice to reduce a PyGFP-luc secondary
liver-stage infectionwhen compared tomock-infectedmice (Fig-
ure 5B), suggesting that CD4+ and CD8+ T cells are dispensable
for innate reduction of liver-stage burden in this model. We also
investigated the role of NK cells and CD1d-dependent NKT cells
in reducing parasite liver-stage burden by utilizing Ly49 knockin
and CD1d/ mice. Ly49 knockin mice overexpress the NK
inhibitory molecule Ly49, resulting in the inhibition of NK cell
maturation (Kim et al., 2000; Kim et al., 2006). Primary liver-stage
infection of Ly49 knockin mice followed by a PyGFP-luc second-
ary liver-stage infection showed a reduced liver-stage burden
that was similar to that seen in C57BL/6 control mice (Figure 5C),
suggesting that NK cells are not playing a predominant role in the
innate reduction of liver-stage burden. However, the reduction of
a PyGFP-luc secondary liver-stage infection in CD1d/ mice
was significantly less pronounced when compared to control
C57BL/6 mice (Figure 5D), indicating that NKT cells are playing
an important role in the innate response that leads to the
elimination of liver-stage parasites. Indeed, intracellular cytokine
staining of liver nonparenchymal cells 72 hpi with PyA revealed
a substantial increase in the total number of IFNg-secretingFigure 2. A Primary Plasmodium Liver-Stage Infection Reduces a Seco
(A) Schematic of the infection protocol. Mice were mock infected with material fro
PyA salivary gland sporozoites on day3 (C57BL/6) or1 (BALB/cJ). On day 0, m
the secondary infection (PyGFP-luc) was monitored by bioluminescent imaging b
(B) Representative rainbow images of luminescence in livers of BALB/cJmice 24 a
expressed in radiance (p/s/cm2/sr).
(C) Quantification of bioluminescent signal in total flux (p/s) from mice in (B) at 24
(D) Quantification of PyGFP-luc liver-stage burden from dissected livers of BALB/
Ratios of Py 18S rRNA to murine GAPDH RNA were calculated and normalized t
(E) Quantification of bioluminescent signal in C57BL/6 mice infected as in (A) at
(F) Quantification of PyGFP-luc liver-stage burden from dissected livers of C57B
(G) BALB/cJ mice were exposed to the bites of 15 mock- or PyA-infected mosq
venously (n = 6 per condition). Bar graphs represent mean ± SD of the data.NKT cells, as defined by positive staining for IFNg, CD3, and
either CD49b or CD1d tetramer compared to mock-infected
mice (Figure 5E). The proportion of NKT cells secreting IFNg
also increased when compared to the total liver lymphocyte
population (Figure 5F). Similar trends were seen for CD4+,
CD8+ T cells, and especially NK cells, which comprised the
largest percentage of IFNg-producing cells, but these cells are
apparently dispensable as effectors as shown in Figures 5B
and 5C. Taken together, these data demonstrate that NKT cells
and specifically CD1d-restricted NKT cells appear to be critical
for the IFNg-mediated reduction of liver infection seen in this
model.
IFNAR/ Mice Recruit Fewer CD49b+ CD3+ Cells to the
Liver after a Primary Liver-Stage Infection
Type I IFN signaling often stimulates cells to produce chemokines
involved in the chemoattraction of leukocytes as well as stimu-
lating cells to produce proinflammatory cytokines, which can
induce the proliferation of immune cells (reviewed in Honda
et al., 2006). To determine if type I IFN signaling is necessary for
the increase in the CD49b+CD3+ NKT cell population in the liver
following PyA primary liver-stage infection, C57BL/6 and
IFNAR/ mice were either mock infected or infected with PyA,
and liver lymphocyte populations were monitored by flow cytom-
etry 72 hpi. NK cells increased in the livers of C57BL/6 and
IFNAR/ infected mice by 2.0- and 1.7-fold, respectively (Fig-
ure6A). Interestingly, thiswasnot thecase for the influxofCD49b+
CD3+NKT cells (Figure 6B). Primary infection inC57BL/6mice re-
sulted in an increase of CD49b+CD3+ NKT cell numbers (approx-
imately 2.5-fold) in the liver (Figure 6B). However, a significantly
reduced fraction of CD49b+CD3+ NKT cells were present in the
livers of IFNAR/ infected mice (1.6-fold increase) (Figure 6B).
An increase in the CD8+ T cell population was also observed in
the livers of infected control mice (Figures 4D and 6C), but not in
infected IFNAR/ mice (Figure 6C). The CD4+ T cell population
did not significantly change in either mouse model (Figure 6D).
Thus, type I IFN signaling appears to be important for the recruit-
ment or expansion of CD49b+CD3+ NKT cells and CD8+ T cells in
the liver following liver-stage infection, but only NKT cells signifi-
cantly contribute to the innate elimination of liver stages.
DISCUSSION
The clinically silent liver stages of Plasmodium represent a
bottleneck in the parasite life cycle, making them an ideal targetndary Infection in BALB/cJ and C57BL/6 Mice
m uninfected mosquito salivary glands (mock) or with 100,000 P. yoelii (Py) or
ice were reinfected with 50,000 PyGFP-luc sporozoites. Liver-stage burden of
etween 24 and 48 hpi.
nd 43 hr after infection with 50,000PyGFP-luc sporozoites. Rainbow scales are
and 43 hpi (n = 10 per condition).
cJ mice initially infected with PyA from (B and C) by qPCR (n = 5 per condition).
o that of PyA-infected mice.
24 and 44 hpi (n = 8 per condition).
L/6 mice from (E) by qPCR (n = 5 per condition).
uitoes and were infected 3 days later with 3,000 PyGFP-luc sporozoites intra-
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Figure 3. Innate Reduction of Liver-Stage
Infection Is Dependent upon Both Type I
and II IFNs
Infection in type I IFN signaling-deficient mice.
(A) C57BL/6 and IFNAR deficient mice (IFNAR/)
were mock infected or infected with 100,000 PyA
sporozoites 3 days prior to a secondary infection
with 50,000 PyGFP-luc sporozoites. Liver-stage
burden of the PyGFP-luc secondary infection was
measured by bioluminescent imaging 44 hpi.
Representative rainbow images of luminescence
in livers of mice 44 hpi are shown. Rainbow scales
are expressed in radiance (p/s/cm2/sr).
(B) Measurement of bioluminescent signal (total
flux [p/s]) in mice from (A) (n = 12 per condition).
Quantification of bioluminescent signal in mice at
44 hpi is depicted (n = 10 animals per condition;
mean ± SD).
(C–E) Control C57BL/6, IRF3-deficient (IRF3/;
n = 10 animals per condition) (C), and IRF7-defi-
cient (IRF7/; n = 7 animals per condition) (D)
mice were infected as in (A). Liver-stage burden
of the secondary infection was monitored by
bioluminescent imaging at 44 hpi. (E) C57BL/6
and IFNg-deficient mice (IFNg/) were infected
as in (A).
Bar graphs represent the mean ± SD of the data.
See also Figure S3.for antimalarial interventions. Although previous histological
studies indicated that pre-erythrocytic infection engenders an
innate immune response, this response remains poorly defined.
Using RNA-seq gene expression analysis, we observed an in-
duction of a type I IFN-mediated innate immune response to
liver-stage infection in mice and connected this to a downstream
type II IFN response. The functionality of these responses was
substantiated using a secondary liver-stage infection in a
model system that is capable of isolating the liver-stage innate
immune response from that elicited by blood-stage infection.
This system demonstrated that the innate immune response
has a pronounced impact on the ability of the parasite to survive
in the liver. We also defined the importance of both type I and442 Cell Reports 7, 436–447, April 24, 2014 ª2014 The Authorstype II IFNs in the innate immune
response to pre-erythrocytic infection,
because mice deficient in IFNg or the
type I IFN receptor IFNAR did not show
an innate suppression of liver-stage
infection. We further demonstrated that
CD1d-restricted NKT cells elicited by
liver-stage infection secrete IFNg and
are necessary for the reduction in liver-
stage burden.
Liver-stage infection resulted in the
enrichment of CD49b+CD3+ NKT cells in
the liver, and this enrichment was depen-
dent upon IFNAR signaling. Although
coexpression of CD49b and CD3 has
traditionally defined NKT cells, some
activated T cells can also increase
CD49b expression (Boisvert et al., 2010;Gagliani et al., 2013; Kassiotis et al., 2006). Thus, these
CD49b+CD3+ cells cannot unequivocally be defined as NKT
cells without further characterization. However, the observation
that many of these cells also bind CD1d tetramer, combined
with the finding that CD1d/ mice did not control a secondary
liver-stage infection, strongly suggests that NKT cells are
increasing in the liver following infection and are able to inhibit
liver-stage infection. These conclusions are supported by a
previous study demonstrating that addition of the glycolipid
a-galactosylceramide, which activates NKT cells, inhibits
Plasmodium liver-stage infection (Gonzalez-Aseguinolaza
et al., 2000). Although the NKT cells in the previous study were
chemically activated, our data demonstrate that NKT cells can
Figure 4. The Increase in the Proportion of
Liver Resident Lymphocytes following a
Parasite Liver-Stage Infection
(A–D) C57BL/6 mice were mock infected or in-
fected with 100,000 PyA sporozoites. Non-
parenchymal cells were isolated from infected
livers 72 hpi, purified on a discontinuous gradient,
and analyzed by flow cytometry. (A) Gating
strategy for identifying lymphocytes in the livers
of mock- and PyA-sporozoite-infected mice. The
lymphocyte population was identified via forward
versus side scatter. Cell populations were then
identified by the following staining pattern: NK
cells (CD49b+CD3), CD49b+CD3+ NKT cells,
CD4 T helper cells (CD4+CD3+), and CD8+ cyto-
toxic T cells (CD8+CD3+).
(B–E) Quantification of NK (B), CD49b+CD3+ NKT
(C), CD8+ T (D), and CD4+ T (E) cells in the livers of
mock- and PyA-infected livers 72 hpi.
(F and G) Nonparenchymal cells from the livers of
mock- or PyA-infected mice were isolated 72 hpi
and analyzed for intracellular cytokine expression
as well as surface expression of molecules above.
(F) Total number of IFNg-positive cells per 100,000
lymphocytes by cell type. (G) Percentage of IFN
g-positive lymphocytes by cell type. Colors cor-
responding to each cell type are shown in legend
and exact percentages are shown in each slice.
Bar graphs represent mean ± SD of the data.
See also Figure S4.be activated by Plasmodium liver-stage infection alone, and thus
our results are of direct biological relevance.
The ability of exogenous IFNg to inhibit development of Plas-
modium liver stages has been described in vitro (Mellouk et al.,
1991; Schofield et al., 1987), but the mechanisms by which
IFNg is induced shortly following a primary liver-stage infection
are not well understood. We show that Plasmodium pre-erythro-
cytic stages can induce an innate IFNg response and that this
response is sufficient to inhibit both a primary and a subsequent
liver-stage infection. Importantly, we also show that NK and NKT
cells from the liver produce IFNg following liver-stage infection.
Higher percentages of NK cells are also found in the liver
following liver-stage infection; however, they do not appear to
have a major effect on reducing liver-stage burden of a second-
ary infection, given that no impact on reduction of liver-stage
infection in Ly49-overexpressing mice was observed. It isCell Reports 7, 436–4unclear why IFNg-producing NK cells
have no or minimal effect on liver-stage
burden, but it potentially indicates that
recognition of a parasite lipid by CD1d-
restricted NKT cells is necessary for para-
site killing.
We show that Plasmodium liver-stage
infection induces a type I IFN response
that can be detected by gene expression
analysis and ELISA. These findings are
in agreement with a recent study by
Liehl et al., which detected a type I
IFN response following infection withP. berghei (Liehl et al., 2014), a parasite that is closely related
to Py but less hepatotropic (Calvo-Calle et al., 1994; Gueirard
et al., 2010; Voza et al., 2012). These convergent findings sug-
gest that the type I IFN response is not unique to Py liver infection
but generally observed in rodent Plasmodium infections.
Liehl et al. also showed that hepatocytes are essential for
sensing of P. berghei parasite RNA via MDA5/MAVS and for
propagating the type I IFN response (Liehl et al., 2014). How-
ever, our results indicate that mice deficient in these signaling
molecules were still able to induce an innate immune response
that was capable of reducing a liver-stage infection. Although
we do not contest that the MDA5 pathway is activated by
liver-stage parasites, our data suggest that multiple or compen-
satory pathways may be involved in generating an effector
innate immune response to Plasmodium liver-stage infection.
The recognition of Plasmodium PAMP by MDA5 would initiate47, April 24, 2014 ª2014 The Authors 443
Figure 5. CD1d-Restricted NKT Cells Are
Necessary to Reduce Liver-Stage Infection
(A) C57BL/6 and lymphocyte-deficient FRG
knockoutmiceweremock infected or infectedwith
100,000PyA3daysprior toan infectionwith50,000
PyGFP-luc sporozoites. Liver-stage burden of the
secondary infection was monitored by biolumi-
nescent imagingat 43hpi (n=5miceper condition).
(B) C57BL/6 mice were treated with control
immunoglobulin G (black bars), CD4+ T cell-
depleting antibody (clone GK 1.5, gray bar), or
CD8+ T cell-depleting antibody (clone 2.43, white
bar) 1 day prior to primary and secondary infec-
tion, and liver-stage burden was measured by
bioluminescent imaging as described in (A).
(C) Liver-stage burden was monitored by biolu-
minescent imaging (total flux [p/s]) at 43 hpi (n = 6
mice per condition). C57BL/6 and Ly49 knockin-
overexpressing mice were infected as in (A) and
imaged at 44 hpi.
(D) C57BL/6 and CD1d-deficient mice were in-
fected as in (A) and liver-stage burden was
determined by bioluminescent imaging at 44 hpi
(n = 8–12 per condition).
Bar graphs represent the mean ± SD of the data.a signaling cascade that results in the activation by phosphory-
lation of the transcription factor IRF3. IRF3 then homo- or heter-
odimerizes with IRF7 to induce transcription of type I IFNs and
several chemokines such as CXCL10. Feedback signaling of
type I IFNs through IFNAR results in signaling via a JAK-STAT
pathway that activates IRF9 to induce the upregulation of IRF7
and IRF7-dependent transcription of IFNa/b (Honda et al.,
2006). In the studies by Liehl et al., the upregulation of inter-
feron-stimulated genes was dependent on both IRF3 and
IRF7, although there was a detectable yet attenuated type I
IFN response in IRF7/ mice (Liehl et al., 2014). Intriguingly,
our data demonstrate that reduction of infection was partially
dependent on the transcription factor IRF3, but not IRF7. These
data were surprising, because these two transcription factors
often work in concert and IRF7 is particularly important in
the escalation of the type I IFN response. Thus, it might be
other IFN response genes, such as IFNg, that are important
for reduction of liver-stage infection, rather than type I IFNs.
Transcriptional regulation of chemokines (CXCL10 for example)
is modulated by homodimers of IRF3. CXCL10 binds to CXCR3
and induces recruitment of leukocytes including T, NK, and
NKT cells into the liver (Groom and Luster, 2011). Importantly,
our RNA-seq data revealed that CXCL10 was significantly
upregulated in the livers of both BALB/cJ and C57BL/6 mice
in response to liver-stage infection. Hence, the importance of
the type I IFN response may be in the IRF3-mediated induction
of chemokines and the subsequent recruitment of innate
effector cells. This hypothesis is particularly intriguing, because
we observed fewer CD49b+CD3+ NKT cells in the livers of
IFNAR-deficient mice following liver-stage infection. Similarly,
recent data from Liehl et al. showed that mononuclear cells
are recruited to late liver-stage parasites and that this recruit-
ment is dependent on type I IFN signaling via hepatocytes
(Liehl et al., 2014).444 Cell Reports 7, 436–447, April 24, 2014 ª2014 The AuthorsUsing our data, combined with recently published findings
(Liehl et al., 2014), we can begin to outline a coherent model of
the innate immune response to Plasmodium parasite infection
in the liver. Infected hepatocytes sense liver-stage parasites,
possibly by detecting their RNA, and trigger a type I IFN
response that recruits inflammatory cells to the site of infection,
likely via chemokines produced downstream of IRF3 signaling.
These IFNg-secreting lymphocytes, particularly NKT cells, are
then able to limit liver-stage parasite infection as demonstrated
by our in vivo infection model.
Taken together, the data presented here contribute to a more
complete understanding of how Plasmodium pre-erythrocytic
stage parasites induce an innate immune response in their target
organ, the liver, and how this response can limit liver-stage para-
site development prior to parasite egress and infection of red
blood cells. Given that innate immune responses are instru-
mental in the shaping of an adaptive immune response, further
elucidation might prove critical in the design of effective pre-
erythrocytic vaccines.
EXPERIMENTAL PROCEDURES
Ethics Statement
All murine studies have been performed according to the regulations of the
institutional animal care and use committee. Approval was obtained from
the Seattle BioMed Experimental Animal Ethical Committee (Office of Labora-
tory Animal Welfare assurance #A3640-01).
Mice
Female Swiss Webster (SW) mice were purchased from Harlan Laboratories;
female BALB/cJ, C57BL/6, TLR3/, and CD1d/ mice, 6–8 weeks of age,
were purchased from Jackson Laboratories; and FRG knockout mice were
purchased from the Yecuris Corporation. IFNg/, IFNAR/, IRF3/,
IRF7/, and TLR4/ mice were kind gifts from Alan Aderem at Seattle
BioMed, and the Ly49+ and TRIF/ mice were a gift from Nick Crispe at
Seattle BioMed.
Figure 6. CD49b+CD3+ NKT Cell Popula-
tions Are Not Increased in the Livers of
Infected IFNAR/ Mice
C57BL/6 mice and IFNAR-deficient mice
(IFNAR/) were mock infected or infected with
100,000 PyA sporozoites. Nonparenchymal cells
were isolated from infected livers 3 days post-
infection, purified on a discontinuous gradient, and
analyzed by flow cytometry as in Figure 3. Percent
of NK cells (A), CD49b+CD3+ cells (B), CD8+ T cells
(C), and CD4+ T cells (D) of the liver lymphocytes
following infection are reported (n = 10 per
condition). Bar graphs represent mean ± SD of
the data.Parasite Growth and Sporozoite Isolation
Female 6- to 8-week old SW mice were injected with blood-stage Py 17XNL
WT, PyGFP-luc, or PyA (deficient in the FabB/F gene) parasites to begin the
growth cycle. The infected mice were used to feed female Anopheles ste-
phensi mosquitoes after gametocyte exflagellation was observed. At day 14
or 15 after blood meal, salivary gland sporozoites were isolated and harvested
as previously described (Tarun et al., 2007).
Infection Assays
Mice were infected with uninfected mosquito salivary gland debris (mock),
100,000 PyA, or WT P. yoelii salivary gland sporozoites in RPMI by intravenous
tail-vein injection or by the bites of 15 mock- or PyA-infected mosquitoes as
described previously (Miller et al., 2013). Approximately 3 days postinfection,
mice received a secondary infection of 1,000, 3,000, or 50,000 PyGFP-luc spo-
rozoites as described in the figure legends. Liver-stage burden of PyGFP-luc
development wasmonitored by in vivo bioluminescence imaging as described
below. Liver-stage burden was also monitored via qPCR as described previ-
ously (Miller et al., 2013). In some cases, liver-stage burdenwas also evaluated
by determining the day of onset of blood-stage parasitemia by analyzing
Giemsa-stained blood smears daily.
In Vivo Bioluminescent Imaging of Liver-Stage Development
Luciferase activity in animals was visualized through imaging of whole bodies
using the in vivo Imaging System (Caliper Life Sciences) as previously
described (Miller et al., 2013). Mice were injected intraperitoneally with
100 ml of RediJect D-Luciferin (Perkin Elmer) prior to being anesthetized using
the isoflurane-anesthesia system (XGI-8, Caliper Life Sciences). Biolumines-
cence images were acquired with a 10 cm field of view, medium binning factor,
and an exposure time of 1–5 min. Quantitative analysis of bioluminescence
was performed by measuring the luminescence signal intensity using the re-
gion of interest (ROI) settings of the Living Image 3.0 software. ROIs were
placed around the abdominal area at the location of the liver and measure-
ments are expressed as total flux (photons/second).
Depletion of T Cell Subtypes
The following antibodies were utilized in infection experiments where specific
cell types were depleted: murine immunoglobulin G, GK1.5 (CD4+ cells), and
2.43 (CD8+ cells). Antibodies were kindly provided by John Harty from the
University of Iowa. Mice were injected with 100 mg of depleting antibody
24 hr before the primary infection and again 24 hr prior to secondary infectionCell Reports 7, 436–4with PyGFP-luc. Depletion of specific cell subsets
(>90%) was confirmed by flow cytometry.
Liver Nonparenchymal Cell Isolation and
Flow Cytometry
Liver nonparenchymal cells were isolated as
described elsewhere (Crispe, 2001). Nonparen-
chymal cells were then stained with the following
antibodies and run on an LSRII for analysis: AlexaFluor 488-conjugated anti-mouse CD3 (clone 145-2C11, BioLegend),
Qdot605-conjugated anti-mouse CD4 (clone RM-45, Life Technologies), BV
711-conjugated anti-mouse CD8 (clone 53-6.7, BioLegend), phycoerythrin
(PE)-conjugated anti-mouse CD49b (clone DX5, eBioscience), APC-conju-
gated aGalCer-loaded CD1d tetramer (NIH Tetramer Core Facility), V450-con-
jugated anti-mouse CD19 (clone 1D3, BD Biosciences), and BV 421-conju-
gated anti-mouse F4/80 (clone BM8, BioLegend). Cells were analyzed with
FlowJo software (Tree Star) and were gated on live lymphocytes via forward
scatter/side scatter as well as V450/BV 421-negative in order to remove B
cells, Kupffer cells, and nonspecifically stained cells from analysis.
For intracellular cytokine staining, nonparenchymal cell isolation was per-
formed as above and 2 3 106 cells were incubated in a 96-well plate with 1X
GolgiPlug (BD Biosciences) for 4 hr prior to fixation/permeabilization with BD
Cytofix/Cytoperm per the manufacturer’s protocol and staining with Alexa
Fluor 488-conjugated anti-mouse CD3, Qdot605-conjugated anti-mouse
CD4, BV 421-conjugated aGalCer-loaded CD1d tetramer, PerCP-Cy5.5-
conjugated anti-mouse F4/80, BV 605-conjugated anti-mouse CD8, APC-
conjugated anti-mouse CD49b, and PE-conjugated anti-mouse IFNg (clone
MOB-47, BioLegend).
Cytokine Detection
IFNg ELISA was performed on serum isolated frommock or PyA-infectedmice
3 days postinfection. Blood from infected mice was isolated by retro-orbital
eye bleed, and serum was separated by centrifugation (6,000 rpm, 20 min).
IFNg concentrations were measured using the mouse IFNg ELISA Ready-
SET-Go! kit from eBioscience (product #88-7314) per the manufacturer’s in-
structions. IFNb concentrations in the livers of mock- or PyA-infected mice
were detected using the mouse IFNb ELISA kit from Thermo Scientific
(product #424001). Three days postinfection, livers were perfused with cold
PBS and homogenized in PBS containing protease inhibitors (cOmplete tab-
lets, Roche Applied Sciences) using a bead beater. The homogenate was
centrifuged for 30 min at 20,000 3 g at 4C, and the supernatant was used
in ELISA per the manufacturer’s instructions.
Microarray and Gene Expression Analysis
BALB/cJ and C57BL/6 mice (n = 4) were mock infected with salivary gland
mosquito debris or with 100,000 PyA salivary gland sporozoites. Three
days postinfection, the livers of infected mice were perfused with Hank’s
balanced salt solution plus EDTA and flash frozen, and RNA was isolated.
RNA from the four replicate mice was combined prior to library formation.47, April 24, 2014 ª2014 The Authors 445
Detailed description of cDNA library generation, sequencing, and analysis can
be found in Supplemental Experimental Procedures. Final RNA-seq data sets
for infected C57BL/6 and BALB/cJ mice are provided as Tables S1, S2, S3,
and S4.
Statistics
All comparisons were two-tailed Student’s t test unless otherwise denoted in
the figure legends. Statistical significances are as follows: *0.05 R p > 0.01;
**0.01R p > 0.001; ***0.001R p > 0.0001; nonsignificant (ns) pR 0.05.
ACCESSION NUMBERS
The NCBI Gene Expression Omnibus accession number for the RNA-seq data
reported in this paper is GSE44831.
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